These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16231029)

  • 1. Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects.
    Kennedy L; Bittel DC; Kibiryeva N; Kalra SP; Torto R; Butler MG
    Int J Obes (Lond); 2006 Feb; 30(2):382-7. PubMed ID: 16231029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial adiponectin levels are unlikely to contribute to the pathogenesis of obesity in Prader-Willi syndrome.
    Caixàs A; Giménez-Palop O; Giménez-Pérez G; Potau N; Berlanga E; González-Glemente JM; Arroyo J; Laferrère B; Mauricio D
    Horm Res; 2006; 65(1):39-45. PubMed ID: 16374018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones.
    Haqq AM; Muehlbauer M; Svetkey LP; Newgard CB; Purnell JQ; Grambow SC; Freemark MS
    Clin Endocrinol (Oxf); 2007 Dec; 67(6):944-51. PubMed ID: 17666087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects.
    Talebizadeh Z; Butler MG
    Clin Genet; 2005 Mar; 67(3):230-9. PubMed ID: 15691361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy.
    Festen DA; van Toorenenbergen A; Duivenvoorden HJ; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1549-54. PubMed ID: 17264186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prader-Willi syndrome is associated with activation of the innate immune system independently of central adiposity and insulin resistance.
    Viardot A; Sze L; Purtell L; Sainsbury A; Loughnan G; Smith E; Herzog H; Steinbeck K; Campbell LV
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3392-9. PubMed ID: 20444923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic profiling in Prader-Willi syndrome and nonsyndromic obesity: sex differences and the role of growth hormone.
    Irizarry KA; Bain J; Butler MG; Ilkayeva O; Muehlbauer M; Haqq AM; Freemark M
    Clin Endocrinol (Oxf); 2015 Dec; 83(6):797-805. PubMed ID: 25736874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of fat distribution in Prader-Willi syndrome: relationships with adipocytokines and influence of growth hormone treatment.
    Tanaka Y; Abe Y; Oto Y; Itabashi H; Shiraishi M; Yoshino A; Obata K; Murakami N; Nagai T
    Am J Med Genet A; 2013 Jan; 161A(1):27-33. PubMed ID: 23239671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index.
    Haqq AM; Muehlbauer MJ; Newgard CB; Grambow S; Freemark M
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E225-32. PubMed ID: 20962018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ghrelin concentrations in Prader-Willi syndrome (PWS) infants and children: changes during development.
    Haqq AM; Grambow SC; Muehlbauer M; Newgard CB; Svetkey LP; Carrel AL; Yanovski JA; Purnell JQ; Freemark M
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):911-20. PubMed ID: 18710462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children.
    Bizzarri C; Rigamonti AE; Luce A; Cappa M; Cella SG; Berini J; Sartorio A; Müller EE; Salvatoni A
    Eur J Endocrinol; 2010 Mar; 162(3):499-505. PubMed ID: 20019130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels.
    Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
    Neuropeptides; 2011 Aug; 45(4):301-7. PubMed ID: 21722955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of leptin protein levels in Prader-Willi syndrome and control individuals.
    Butler MG; Moore J; Morawiecki A; Nicolson M
    Am J Med Genet; 1998 Jan; 75(1):7-12. PubMed ID: 9450849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased serum resistin in adults with prader-willi syndrome is related to obesity and not to insulin resistance.
    Pagano C; Marin O; Calcagno A; Schiappelli P; Pilon C; Milan G; Bertelli M; Fanin E; Andrighetto G; Federspil G; Vettor R
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4335-40. PubMed ID: 15870134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome in adult patients with Prader-Willi syndrome.
    Grugni G; Crinò A; Bedogni G; Cappa M; Sartorio A; Corrias A; Di Candia S; Gargantini L; Iughetti L; Pagano C; Ragusa L; Salvatoni A; Spera S; Vettor R; Chiumello G; Brambilla P
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1134-40. PubMed ID: 23220075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between metabolic syndrome, cytokines and physical activity in obese youth with and without Prader-Willi syndrome.
    McAlister KL; Fisher KL; Dumont-Driscoll MC; Rubin DA
    J Pediatr Endocrinol Metab; 2018 Aug; 31(8):837-845. PubMed ID: 29975666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irisin and the Metabolic Phenotype of Adults with Prader-Willi Syndrome.
    Hirsch HJ; Gross I; Pollak Y; Eldar-Geva T; Gross-Tsur V
    PLoS One; 2015; 10(9):e0136864. PubMed ID: 26334732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenarche in Prader-Willi syndrome appears not related to insulin sensitivity and serum adiponectin.
    Unanue N; Bazaes R; Iñiguez G; Cortés F; Avila A; Mericq V
    Horm Res; 2007; 67(3):152-8. PubMed ID: 17085944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fat-Free Mass Is Better Related to Serum Uric Acid Than Metabolic Homeostasis in Prader-Willi Syndrome.
    Marzullo P; Mele C; Minocci A; Mai S; Scacchi M; Sartorio A; Aimaretti G; Grugni G
    Nutrients; 2020 Aug; 12(9):. PubMed ID: 32854398
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma cholecystokinin levels in Prader-Willi syndrome and obese subjects.
    Butler MG; Carlson MG; Schmidt DE; Feurer ID; Thompson T
    Am J Med Genet; 2000 Nov; 95(1):67-70. PubMed ID: 11074497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.